drugset / Trial / NCT04280055

Prophylactic Effects of Psilocybin on Chronic Cluster Headache

NCT04280055

Phase 1/2 Terminated 10 enrolled Gitte Moos Knudsen
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the prophylactic effects of psilocybin in chronic cluster headache. Subjects will receive a low dose of psilocybin during 3 sessions spaced by one week. Subjects will maintain a headache diary prior to, during, and after the administrations in order to document headache frequency, intensity and duration. Subjects will undergo a fMRI scanning before the first and after the last psilocybin session.

Timeline

Start
2020-01-21
Primary completion
2020-11-01
Completion
2022-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Psilocybin Other / unclassified 0.14 mg/kg Oral